We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

34 hedge funds and large institutions have $59.8M invested in T2 Biosystems, Inc in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3434 (0)

0% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 13

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

44% less capital invested

Capital invested by funds: $107M → $59.8M (-$47.2M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $4K

Holders
34
Holders Change
Holders Change %
0%
% of All Funds
0.85%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
13
Increased
6
Reduced
7
Closed
13
Calls
Puts
$4K
Net Calls
-$4K
Net Calls Change
+$51K
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$13.7M +$60.1K +3 +0.4%
SM
2
Senvest Management
New York
$9.11M +$1.5M +75 +15%
LIM
3
Lagoda Investment Management
New York
$6.34M +$1.06M +53 +15%
FP
4
Flagship Pioneering
Massachusetts
$6.26M
PVMCV
5
Polaris Venture Management Co V
Massachusetts
$6.02M
TM
6
Tiger Management
New York
$5.58M +$1.48M +74 +27%
AC
7
Aisling Capital
New York
$4.89M -$5.23M -261 -46%
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.89M -$240K -12 -9%
Fuller & Thaler Asset Management
9
Fuller & Thaler Asset Management
California
$1.72M +$2.14M +107 New
EIM
10
Essex Investment Management
Massachusetts
$668K +$581K +29 +223%
Millennium Management
11
Millennium Management
New York
$611K +$280K +14 +58%
BlackRock
12
BlackRock
New York
$491K -$2.34M -117 -79%
BCM
13
Bridgeway Capital Management
Texas
$436K
Geode Capital Management
14
Geode Capital Management
Massachusetts
$304K -$100K -5 -21%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$275K +$341K +17 New
ECM
16
Element Capital Management
New York
$230K +$280K +14 New
LP
17
LMR Partners
United Kingdom
$180K +$220K +11 New
PP
18
Paloma Partners
Connecticut
$177K +$220K +11 New
Northern Trust
19
Northern Trust
Illinois
$153K -$501K -25 -71%
Morgan Stanley
20
Morgan Stanley
New York
$153K
CS
21
Credit Suisse
Switzerland
$134K +$160K +8 New
Barclays
22
Barclays
United Kingdom
$75K +$100K +5 New
KeyBank National Association
23
KeyBank National Association
Ohio
$64K +$80.1K +4 New
VKH
24
Virtu KCG Holdings
New York
$51K +$60.1K +3 New
RFS
25
Rockefeller Financial Services
New York
$48K

TTOO Hedge Fund Activity: Q2 2017 in Review

34 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2017, worth a combined $59.8M — down 44% from $107M a quarter earlier.

Fund positioning in TTOO was balanced in Q2 2017: 13 funds opened new positions, 13 closed out, 6 added to existing stakes and 7 trimmed.

The largest buyer was Fuller & Thaler Asset Management, opening a new position worth an estimated $2.14M. The largest seller was Wellington Management Group, exiting entirely with an estimated $6.66M sold.

  • 34 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $59.8M of T2 Biosystems, Inc stock for Q2 2017, down 44% quarter-over-quarter.
  • 13 funds opened new T2 Biosystems, Inc positions in Q2 2017 and 13 closed out, a net change of 0 holders.
  • The largest T2 Biosystems, Inc buyer in Q2 2017 was Fuller & Thaler Asset Management, an estimated $2.14M added.
  • The largest T2 Biosystems, Inc seller in Q2 2017 was Wellington Management Group, an estimated $6.66M sold.

Based on aggregated 13F filings for Q2 2017.